Search research articles
Contact Us
Filters
Showing results (61-70 of 225) with videos related to
Page
of 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo
Patrick Roth, Maria Kissel, Caroline Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
Alexandros Papachristodoulou, Manuela Silginer, Michael Weller, et al.
Journal of Neurochemistry
|
February 27, 2018
Transcriptional control of O<sup>6</sup> -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma
Caroline Happold, Nina Stojcheva, Manuela Silginer, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Multiple Sclerosis and Related Disorders
|
December 19, 2025
Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis
Lea I Walter, Veronika Kana, Sarah Hösli, et al.
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype
Claudio Togni, Emanuel Rom, Isabel Burghardt, et al.
Journal of the Neurological Sciences
|
February 12, 2026
Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disorders
Lorenz Karnbrock, Marina Herwerth, Guido Vincent Bloemberg, et al.
Neuro-Oncology Advances
|
July 10, 2020
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
Birthe Lohmann, Manuela Silginer, Daniel Picard, et al.
Oncotarget
|
January 8, 2016
Control of glioma cell migration and invasiveness by GDF-15
Paula Codó, Michael Weller, Kerstin Kaulich, et al.
Oncotarget
|
October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo, Michael Weller, Gunter Meister, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 225) with videos related to
Sort By:
Page
of 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo
Patrick Roth, Maria Kissel, Caroline Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2019
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
Alexandros Papachristodoulou, Manuela Silginer, Michael Weller, et al.
Journal of Neurochemistry
|
February 27, 2018
Transcriptional control of O<sup>6</sup> -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma
Caroline Happold, Nina Stojcheva, Manuela Silginer, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Multiple Sclerosis and Related Disorders
|
December 19, 2025
Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis
Lea I Walter, Veronika Kana, Sarah Hösli, et al.
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype
Claudio Togni, Emanuel Rom, Isabel Burghardt, et al.
Journal of the Neurological Sciences
|
February 12, 2026
Persistent parvovirus B19 DNAemia in B-cell depletion: Implications for family planning in multiple sclerosis and related disorders
Lorenz Karnbrock, Marina Herwerth, Guido Vincent Bloemberg, et al.
Neuro-Oncology Advances
|
July 10, 2020
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
Birthe Lohmann, Manuela Silginer, Daniel Picard, et al.
Oncotarget
|
January 8, 2016
Control of glioma cell migration and invasiveness by GDF-15
Paula Codó, Michael Weller, Kerstin Kaulich, et al.
Oncotarget
|
October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo, Michael Weller, Gunter Meister, et al.
Page
of 23